Risk Materials

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

Renal and bone effects risk minimisation material: Tenofovir disoproxil for children and adolescents with HIV-1

This brochure provides important advice on the management of potential renal and bone effects of tenofovir disoproxil in HIV-1 infected children and adolescents aged 2 to <18 years, and on the dosing recommendations for tenofovir disoproxil in this population.

For Healthcare Professionals

Renal Risk Minimisation Material: Tenofovir Disoproxil for adolescent children with chronic hepatitis B

This brochure provides important advice on the management of potential renal and bone effects of tenofovir disoproxil in adolescent patients with chronic hepatitis B aged 12 to <18 years, and on the dosing recommendations for tenofovir disoproxil in this population.

For Healthcare Professionals

Send us feedback

If you would like to make a comment or send us feedback on this material, click here.